Manginsay, Florie M.
HRN: 03 52 18 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
01/25/2025
AMPICILLIN 1GM + SULBACTAM 500MG (VIAL)
01/25/2025
01/31/2025
IV INFUSION
1.5gm
Q6
Infected Wound
Waiting Final Action
Indication: Empiric Type of Infection: Skin & Soft Tissue Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes